Dynamic Audience Activation Puts the “Best” in Next-Best Action
Despite life sciences manufacturers’ considerable planning and investment in HCP engagement programs, too often their message falls short of reaching their target audience....
Despite life sciences manufacturers’ considerable planning and investment in HCP engagement programs, too often their message falls short of reaching their target audience....
In today’s complex healthcare landscape, keeping up with the latest therapies and treatments can be an overwhelming task for many healthcare professionals (HCPs) particularly...
In life science brands’ quest for highly targeted, clinically-relevant HCP communications, EHR “trigger” data is an increasingly popular choice. Its benefits include accuracy...
Life science brand’s need for effective HCP engagement solutions at the point of care (POC) is...
Omnichannel programs are at the forefront of today’s HCP engagement strategies – and for good reason. In a March 2023 survey, OptimizeRx found that physicians were actively...
Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value,...
Omnichannel marketing and artificial intelligence (AI) have made targeting clinical audiences easier and more precise. And yet, in the life sciences, we still tend to engage...
Pharma and MedTech companies continue to spend billions marketing drugs and devices to physicians. In fact, according to Forbes, pharma spent nearly $4 billion on advertising...
OptimizeRx has released its second Environment, Social and Governance (ESG) report. The report details the Company’s efforts to align with, and show progress against, the 21...